Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Choroideremia: molecular mechanisms and development of AAV gene therapy.

Journal article

Patrício MI. et al, (2018), Expert Opin Biol Ther, 18, 807 - 820

Vector shedding and immunology results from a gene therapy clinical trial for choroideremia

Conference paper

Barnard AR. et al, (2018), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 59

Vector Shedding and Immunogenicity Sampling for Retinal Gene Therapy.

Journal article

Barnard AR. et al, (2018), Methods Mol Biol, 1715, 359 - 371

Gene Therapy for Color Blindness.

Journal article

Hassall MM. et al, (2017), Yale J Biol Med, 90, 543 - 551

Prenylation of Rab6a as a Potency Assay for Choroideremia Gene Therapy

Journal article

Patricio MI. et al, (2017), MOLECULAR THERAPY, 25, 142 - 143

Load More